Scholarlink

Purpose of Review <p>Spontaneous coronary artery dissection (SCAD) is an underrecognized cause of acute coronary syndrome, primarily affecting younger women without traditional risk factors. This review synthesizes current knowledge, identifies research gaps, and explores how precision medicine can improve diagnosis, treatment, and patient outcomes.</p> Recent Findings <p>SCAD is clinically and biologically heterogeneous, with variation in presentation, etiology, and recurrence risk. Contributing factors include sex-specific hormonal differences, vascular abnormalities, genetic predisposition, psychosocial stressors, and social determinants of health. Despite growing awareness, major gaps persist in risk stratification and tailored care. Emerging tools, including genomics, radiomics, and multiomics, offer opportunities to define SCAD subtypes and personalized management.</p> Summary <p>A precision medicine framework integrating molecular, imaging, and social data may transform SCAD care. Continued research is essential to improve early detection, optimize therapy, and reduce recurrence.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月15日

查看全文
  • Cristiane C. Singulane,
  • Shuo Wang,
  • Kelsey Watts,
  • Macy E. Stahl,
  • LeAnn Denlinger,
  • Rachel Lloyd,
  • Pranavi Pallinti,
  • Lauren Preston,
  • Mohamed Morsy,
  • Odayme Quesada,
  • Angela Taylor,
  • Randy K. Ramcharitar,
  • Mete Civelek,
  • Patricia F. Rodriguez-Lozano

摘要

Purpose of Review

Spontaneous coronary artery dissection (SCAD) is an underrecognized cause of acute coronary syndrome, primarily affecting younger women without traditional risk factors. This review synthesizes current knowledge, identifies research gaps, and explores how precision medicine can improve diagnosis, treatment, and patient outcomes.

Recent Findings

SCAD is clinically and biologically heterogeneous, with variation in presentation, etiology, and recurrence risk. Contributing factors include sex-specific hormonal differences, vascular abnormalities, genetic predisposition, psychosocial stressors, and social determinants of health. Despite growing awareness, major gaps persist in risk stratification and tailored care. Emerging tools, including genomics, radiomics, and multiomics, offer opportunities to define SCAD subtypes and personalized management.

Summary

A precision medicine framework integrating molecular, imaging, and social data may transform SCAD care. Continued research is essential to improve early detection, optimize therapy, and reduce recurrence.